wds004

William D. Schlaff, MD

Contact Dr. Schlaff

833 Chestnut Street
Mezzanine
Philadelphia, PA 19107

(215) 955-5000

Most Recent Peer-reviewed Publications

  1. Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype
  2. Optimal approaches to fibroid management: Consider fibroid location and the patient’s pregnancy plans
  3. Recruitment strategies in two reproductive medicine network infertility trials
  4. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations
  5. Autonomy, futility, and good business in reproductive medicine: Is the slope getting more slippery?
  6. Performance of embryo transfer in fellowship training
  7. Introduction Role of mental health professionals in the care of infertile patients
  8. Introduction Mental health counseling in third party reproduction
  9. Fellowship training and board certification in reproductive endocrinology and infertility
  10. Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes
  11. Impact of male and female weight, smoking, and intercourse frequency on live birth in women with polycystic ovary syndrome
  12. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome
  13. Smoking in infertile women with polycystic ovary syndrome: Baseline validation of self-report and effects on phenotype
  14. Responding to change in reproductive endocrinology fellowships
  15. Medical treatments for endometriosis-related pain
  16. The pregnancy in polycystic ovary syndrome II study: Baseline characteristics and effects of obesity from a multicenter randomized clinical trial
  17. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome
  18. Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome
  19. Altering hirsutism through ovulation induction in women with polycystic ovary syndrome
  20. The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: Rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome